Pharmaceutical Industry Perspective on the Non-Clinical Evaluation of Novel Excipients: Results From an Industry Survey Conducted by the IQ Novel Excipient Working Group.

Giffen, Paul S; Buckley, Lorrene A; Pinkstaff, Jason

Giffen, Paul S; Buckley, Lorrene A; Pinkstaff, Jason.

Afiliação

Giffen PS; Clinical Pharmacology and Safety Sciences, AstraZeneca Pharmaceuticals, Cambridge, UK.
Buckley LA; Toxicology and Drug Disposition, Lilly Corporate Center, Eli Lilly and Co. Inc, Indianapolis, IN, USA.
Pinkstaff J; Drug Safety Research and Development, Pfizer, Inc, La Jolla, CA, USA.

Int J Toxicol ; 42(6): 480-488, 2023 12.

Article em En | MEDLINE | ID: mdl-37450849

Assuntos

Indústria Farmacêutica; Excipientes; Excipientes/toxicidade; Preparações Farmacêuticas

Palavras-chave

IQ; excipient; guidance; industry; non-clinical development; novel excipient; pharmaceutical; safety assessment; survey

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Indústria Farmacêutica / Excipientes Tipo de estudo: Guideline Idioma: En Revista: Int J Toxicol Assunto da revista: TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google